Ultrasound biomicroscopy, anterior segment-optical coherence tomography useful adjuncts
July 1st 2012Gonioscopy remains the gold standard technique for assessing the anterior chamber angle, but ultrasound biomicroscopy and anterior segment optical coherence tomography can be useful adjuncts for glaucoma patient care.
Intraocular lens yields good functional results
June 15th 2012Results of defocus curve testing in eyes with a refractive multifocal IOL implanted as part of a prospective, multicenter comparative trial are better for the +3-D near-add version of the lens compared with the +4-D near-add platform with regard to intermediate visual acuity.
Intentional anisometropia creation treats diplopia
June 15th 2012Planned anisometropia in patients with long-standing diplopia who are undergoing bilateral cataract surgery can be a triple-win situation, providing clear uncorrected vision at both distance and near while simultaneously eliminating or reducing awareness of pre-existing double vision.
Smartphones a boon for visually impaired
May 23rd 2012Smartphones can be a big help to the visually impaired, but few eye-care professionals (ECPs) are recommending them to patients, according to the results of a study presented at this year’s annual meeting of the Association for Research in Vision and Ophthalmology.
Anesthesia in children linked to learning disabilities?
May 23rd 2012The jury is still out on the effects of anesthesia in children who undergo surgery at a young age, according to Constance S. Houck, MD. Multiple animal studies have demonstrated neuroapoptosis and long-term learning deficits in young animals after administration of general anesthesia, but population-based studies in humans have been far less clear.
AMO chief to retire; successor named
May 23rd 2012Abbott Medical Optics (AMO) has announced an impending change in leadership with the expected retirement of James V. Mazzo, president and chief executive officer (CEO), by the end of this year. Mazzo will be succeeded by Murthy Simhambhatla, PhD, who currently heads the Ibis Biosciences division of AMO’s parent company, Abbott Laboratories.